Inovio Pharmaceuticals, Inc, a Plymouth Meeting-based pharmaceutical company, plans to begin trials of the vaccine on humans in April, with one million doses of the vaccine produced for emergency use by years’ end.
User ID / Email / Password is case sensitive
To inquire about group subscriptions or an enterprise site license for your organization, contact Tracy Bumba
Get Essential Business News
1 Year Print & Digital
1 Year Print +Digital + Data Joe (BOL)
Monthly Digital Only
First time registering your paid subscription? Click here
Having trouble with login?
Please contact [email protected].